Kush Parmar – Biography
Last update: February 24, 2026Executive profile
Kush was Board Member for scPharmaceuticals. Kush served as Chief Executive Officer and Chairman at 5AM Ventures.
Kush Parmar is currentlyCo-Managing Partner at 5AM Ventures - View - 5AM Ventures org chart
Director at Ensoma - View - Ensoma org chart
Director at Entrada Therapeutics - View - Entrada Therapeutics org chart
Director at GlycoEra - View - GlycoEra org chart
Independent Director at Syngene - View - Syngene org chart
Create your alert
to follow the career of Kush Parmar.
Education
In 2010, Kush Parmar completed a PhD in Biomedical Sciences at Harvard University.
They have also studied at Harvard University :
Find more alumni from Harvard University
More about Kush Parmar
Do you need to know more about Kush Parmar? More results.
Participate
Social media
- Kush Parmar on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Kush Parmar
The colleagues of Kush Parmar
Company Colleagues
- At 5AM Ventures, Kush Parmar has 23 colleagues including Andrew Schwab (Co-Managing Partner), John Diekman (Founding Partner)…
- At Ensoma, Kush Parmar has 18 colleagues including Jim Burns (CEO & Director), Albert Seymour (Director)…
- At Entrada Therapeutics, Kush Parmar has 29 colleagues including Dipal Doshi (CEO), Bernhardt Zeiher (Director)…
- At GlycoEra, Kush Parmar has 13 colleagues including Ganesh Kaundinya (CEO), Sohaib Mir (Director)…
- At Syngene, Kush Parmar has 41 colleagues including Peter Bains (CEO (-> Jun 30 2026)), Siddharth Mittal (CEO (Jul 1 2026 ->))…
Industry Colleagues
- In the Fund industry, Kush Parmar has 30,049 colleagues in 1,643 companies located in 64 countries. 10,503 executive movements have been recorded in the last 12 months. Learn more about Fund.
Report an error
Update the org chart details of Kush Parmar.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Kush Parmar.
